These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 32986426)
21. Multi-Objective Drug Design Based on Graph-Fragment Molecular Representation and Deep Evolutionary Learning. Mukaidaisi M; Vu A; Grantham K; Tchagang A; Li Y Front Pharmacol; 2022; 13():920747. PubMed ID: 35860028 [TBL] [Abstract][Full Text] [Related]
22. Docking and Virtual Screening in Drug Discovery. Kontoyianni M Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009 [TBL] [Abstract][Full Text] [Related]
23. Structure-Based Drug Design with a Deep Hierarchical Generative Model. Weller JA; Rohs R J Chem Inf Model; 2024 Aug; 64(16):6450-6463. PubMed ID: 39058534 [TBL] [Abstract][Full Text] [Related]
24. Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration. Chen L; Shen Q; Lou J BMC Bioinformatics; 2023 Apr; 24(1):173. PubMed ID: 37101113 [TBL] [Abstract][Full Text] [Related]
25. Molecular substructure tree generative model for de novo drug design. Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853 [TBL] [Abstract][Full Text] [Related]
26. Quantum-Mechanics Methodologies in Drug Discovery: Applications of Docking and Scoring in Lead Optimization. Crespo A; Rodriguez-Granillo A; Lim VT Curr Top Med Chem; 2017; 17(23):2663-2680. PubMed ID: 28685695 [TBL] [Abstract][Full Text] [Related]
27. DockingGA: enhancing targeted molecule generation using transformer neural network and genetic algorithm with docking simulation. Gao C; Bao W; Wang S; Zheng J; Wang L; Ren Y; Jiao L; Wang J; Wang X Brief Funct Genomics; 2024 Sep; 23(5):595-606. PubMed ID: 38582610 [TBL] [Abstract][Full Text] [Related]
28. Generative model based on junction tree variational autoencoder for HOMO value prediction and molecular optimization. Kondratyev V; Dryzhakov M; Gimadiev T; Slutskiy D J Cheminform; 2023 Feb; 15(1):11. PubMed ID: 36732800 [TBL] [Abstract][Full Text] [Related]
29. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space. Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756 [TBL] [Abstract][Full Text] [Related]
30. Optimization of binding affinities in chemical space with generative pre-trained transformer and deep reinforcement learning. Xu X; Zhou J; Zhu C; Zhan Q; Li Z; Zhang R; Wang Y; Liao X; Gao X F1000Res; 2023; 12():757. PubMed ID: 38434657 [TBL] [Abstract][Full Text] [Related]
31. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning. Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022 [TBL] [Abstract][Full Text] [Related]
32. Docking optimization, variance and promiscuity for large-scale drug-like chemical space using high performance computing architectures. Trager RE; Giblock P; Soltani S; Upadhyay AA; Rekapalli B; Peterson YK Drug Discov Today; 2016 Oct; 21(10):1672-1680. PubMed ID: 27352630 [TBL] [Abstract][Full Text] [Related]
34. Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands. Shen J; Yang XC; Yu MC; Xiao L; Zhang XJ; Sun HJ; Chen H; Pan GX; Yan YR; Wang SC; Li W; Zhou L; Xie Q; Yu LQ; Wang YH; Shao LM Acta Pharmacol Sin; 2017 Jan; 38(1):146-155. PubMed ID: 27917874 [TBL] [Abstract][Full Text] [Related]
35. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins. Yan S; Elmes MW; Tong S; Hu K; Awwa M; Teng GYH; Jing Y; Freitag M; Gan Q; Clement T; Wei L; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Wang L; Bogdan DM; Falcone J; Smietalo N; Zhou Y; Ralph B; Hsu HC; Li H; Rizzo RC; Deutsch DG; Kaczocha M; Ojima I Eur J Med Chem; 2018 Jun; 154():233-252. PubMed ID: 29803996 [TBL] [Abstract][Full Text] [Related]
36. Graph-based generative models for de Novo drug design. Xia X; Hu J; Wang Y; Zhang L; Liu Z Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094 [TBL] [Abstract][Full Text] [Related]
38. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships. Naqvi AAT; Mohammad T; Hasan GM; Hassan MI Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721 [TBL] [Abstract][Full Text] [Related]
39. De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment. Fang Y; Pan X; Shen HB Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36961341 [TBL] [Abstract][Full Text] [Related]
40. [Computational chemistry in structure-based drug design]. Cao R; Li W; Sun HZ; Zhou Y; Huang N Yao Xue Xue Bao; 2013 Jul; 48(7):1041-52. PubMed ID: 24133970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]